Last reviewed · How we verify
Susu Xiao'er Zhike Granules
Susu Xiao'er Zhike Granules is a traditional Chinese medicine formula that has been studied for its potential anti-inflammatory and immunomodulatory effects.
Susu Xiao'er Zhike Granules is a traditional Chinese medicine formula that has been studied for its potential anti-inflammatory and immunomodulatory effects. Used for Treatment of rheumatoid arthritis.
At a glance
| Generic name | Susu Xiao'er Zhike Granules |
|---|---|
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of Susu Xiao'er Zhike Granules is not well understood, but it is believed to involve the modulation of immune responses and the reduction of inflammation. This may be achieved through the interaction of various bioactive compounds present in the formula, including flavonoids, alkaloids, and saponins.
Approved indications
- Treatment of rheumatoid arthritis
Common side effects
- Gastrointestinal upset
Key clinical trials
- Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment (PHASE3)
- Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Susu Xiao'er Zhike Granules CI brief — competitive landscape report
- Susu Xiao'er Zhike Granules updates RSS · CI watch RSS
- Tasly Pharmaceutical Group Co., Ltd portfolio CI